Boehringer Ingelheim has launched Vetmedin (pimobendan) 1.5 mg/ml oral solution for dogs in the UK, offering a new treatment ...

Krka has launched Arocenia (maropitant) 10 mg/ml injectable solution, licensed for the prevention and treatment of vomiting in dogs and cats, including ...

The Royal Veterinary College has published new data from its VetCompass programme which shed new light on the epidemiology, risk factors and outcomes for ...

“However, there is more to be done, and the findings of this study emphasise a significant need for the veterinary profession to come together and do more to acknowledge and raise awareness of the ...

The Society of Practising Veterinary Surgeon (SPVS) has published the results of its 2025 Salary Survey, which found that veterinary salary increase have ...

A study published in Frontiers in Veterinary Science , has identified a gene called SLAMF1 that significantly increases the risk of developing canine ...

Tickets have gone on sale for Vets Now's annual Emergency and Critical Care (ECC) Congress, taking place on Thursday 6th and Friday 7th November 2025 at ...

SPVS has announced that the award-winning speaker and best-selling author, Richard Gerver, will open its 2026 Congress taking ...

The company says that although some UK insurers are continuing to offer protection to existing policy holders, Agria is one of the few insurers to offer lifetime veterinary fee cover to new customers.

LacriProtect is designed to increase the depth of the tear film in the management of dry eye, during anaesthesia, or in case of irritation. It contains a carbomer-based formula in individual, ...

The maps provide vets with a visual representation of targeted diagnostic tests conducted in France, Germany, Ireland, Italy, Spain, and the UK, using data sourced from Idexx. They show the percentage ...

The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters. The new Vetoryl tablets will come in packs of 30 tablets, although ...